Request Demo
Last update 08 May 2025
Betamethasone dipropionate/Bexarotene
Last update 08 May 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Bexarotene/betamethasone dipropionate |
Target |
Action agonists |
Mechanism GR agonists(Glucocorticoid receptor agonists), RXRA agonists(Retinoid X receptor alpha agonists), RXRB agonists(Retinoid X receptor beta agonists) + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Structure/Sequence
Molecular FormulaC28H37FO7 |
InChIKeyCIWBQSYVNNPZIQ-XYWKZLDCSA-N |
CAS Registry5593-20-4 |
View All Structures (2)
Related
7
Clinical Trials associated with Betamethasone dipropionate/BexaroteneNCT02955693
Randomized, Open-label, Single-center, Four-way Crossover, Single Dose Study to Investigate the Pharmacokinetics of LAS41008 120 mg Gastro-resistant Tablet and Fumaderm® 120 mg Gastro-resistant Tablet Under Fasting and Fed Conditions in Healthy Subjects
NCT02180464
A Phase IIa, 28-day Treatment, Multi-center, Randomized, Comparator-controlled, Observer-blind Trial With Intra-individual Left/Right Comparison to Investigate the Anti-psoriatic Efficacy and the Safety of an LAS41004 Formulation in Comparison to an Active Reference in Patients With Mild to Moderate Plaque Psoriasis
NCT02111499
A Randomized, Controlled, Observer-blind Psoriasis Plaque Test to Investigate the Anti-psoriatic Efficacy, Tolerability and Safety (Skin Atrophy) of LAS41004 Formulations in Patients With Mild to Moderate Plaque Psoriasis
100 Clinical Results associated with Betamethasone dipropionate/Bexarotene
Login to view more data
100 Translational Medicine associated with Betamethasone dipropionate/Bexarotene
Login to view more data
100 Patents (Medical) associated with Betamethasone dipropionate/Bexarotene
Login to view more data
100 Deals associated with Betamethasone dipropionate/Bexarotene
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Psoriasis | Phase 2 | United Kingdom | 01 Sep 2016 | |
| Atrophy | Phase 2 | Germany | 01 Mar 2014 | |
| Arthritis, Psoriatic | Phase 2 | Germany | 01 Aug 2011 | |
| Plaque psoriasis | Phase 2 | Germany | 01 May 2011 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free